| Q58648340 | Applying Nanotechnology to Human Health: Revolution in Biomedical Sciences |
| Q34396714 | Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies |
| Q36358722 | Biocompatibility of chitosan-coated iron oxide nanoparticles with osteoblast cells |
| Q90415248 | Blood Clearance of Citric Acid-Coated Superparamagnetic Iron Oxide Nanoparticles in Rats - a Pilot Study |
| Q35377505 | Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography. |
| Q47808293 | Cancer cell death induced by nanomagnetolectin. |
| Q34278921 | Cardiac-targeting magnetic lipoplex delivery of SH-IGF1R plasmid attenuate norepinephrine-induced cardiac hypertrophy in murine heart |
| Q35972543 | Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery |
| Q37194020 | Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy |
| Q42069004 | Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility |
| Q36044414 | Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy. |
| Q41477504 | Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe3O4 nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug |
| Q39158342 | Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy |
| Q40107601 | Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics |
| Q36392994 | High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents |
| Q59125462 | Hybrid Nanomaterials Based on Iron Oxide Nanoparticles and Mesoporous Silica Nanoparticles: Overcoming Challenges in Current Cancer Treatments |
| Q33577102 | In vitro biocompatibility study of sub-5 nm silica-coated magnetic iron oxide fluorescent nanoparticles for potential biomedical application |
| Q40061354 | Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors |
| Q28085546 | Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery |
| Q39420717 | Local gene targeting and cell positioning using magnetic nanoparticles and magnetic tips: comparison of mathematical simulations with experiments |
| Q45010796 | MRI after magnetic drug targeting in patients with advanced solid malignant tumors |
| Q46469524 | Magnetic drug targeting. New paths for the local concentration of drugs for head and neck cancer |
| Q37376480 | Magnetic nanoparticle drug carriers and their study by quadrupole magnetic field-flow fractionation |
| Q27004205 | Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy |
| Q39896527 | Magnetic targeting of iron-oxide-labeled fluorescent hepatoma cells to the liver |
| Q33617175 | Magnetically targeted viral envelopes: a PET investigation of initial biodistribution |
| Q37984489 | Magnetically vectored platforms for the targeted delivery of therapeutics to tumors: history and current status |
| Q36058854 | Manipulation of magnetic nanoparticle retention and hemodynamic consequences in microcirculation: assessment by laser speckle imaging |
| Q41095433 | Multifunctional Particles: Magnetic Nanocrystals and Gold Nanorods Coated with Fluorescent Dye-Doped Silica Shells |
| Q37314628 | Multifunctional and stimuli-sensitive pharmaceutical nanocarriers |
| Q37990023 | Nanoparticles for cancer therapy using magnetic forces |
| Q37059886 | Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles. |
| Q42181688 | Optimal Halbach Permanent Magnet Designs for Maximally Pulling and Pushing Nanoparticles |
| Q30412855 | Physical energy for drug delivery; poration, concentration and activation. |
| Q41602564 | Planar Steering of a Single Ferrofluid Drop by Optimal Minimum Power Dynamic Feedback Control of Four Electromagnets at a Distance |
| Q37524376 | Real-time monitoring of magnetic drug targeting using fibered confocal fluorescence microscopy. |
| Q38102018 | Recent advances in superparamagnetic iron oxide nanoparticles for cellular imaging and targeted therapy research |
| Q50454153 | Some thoughts on the therapy of hearing disturbances in the future |
| Q39794977 | Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking |
| Q38908640 | Superparamagnetic MFe2O 4 (M = Ni, Co, Zn, Mn) nanoparticles: synthesis, characterization, induction heating and cell viability studies for cancer hyperthermia applications. |
| Q41957148 | Tangential Flow Ultrafiltration Allows Purification and Concentration of Lauric Acid-/Albumin-Coated Particles for Improved Magnetic Treatment |
| Q54647504 | Targeted Delivery of Protein Drugs by Nanocarriers. |
| Q58996846 | Targeted, Monitored, and Controlled Chemotherapy: A Multimodal Nanotechnology-Based Approach against Cancer |
| Q46919648 | Targeting cancer cells: magnetic nanoparticles as drug carriers |
| Q53321113 | Tumor regression by means of magnetic drug targeting. |
| Q39159310 | Tumour cell labelling by magnetic nanoparticles with determination of intracellular iron content and spatial distribution of the intracellular iron. |
| Q38275454 | Uptake and fate of surface modified silica nanoparticles in head and neck squamous cell carcinoma. |
| Q38096614 | Urinary catheterization of male rabbits: a new technique and a review of urogenital anatomy |
| Q36917951 | Use of degradable and nondegradable nanomaterials for controlled release |
| Q35403421 | Visual bone marrow mesenchymal stem cell transplantation in the repair of spinal cord injury |
| Q50283433 | Visualization of superparamagnetic nanoparticles in vascular tissue using XμCT and histology |
| Q37643745 | X-ray microcomputed tomography as a tool for the investigation of the biodistribution of magnetic nanoparticles |
| Q85654698 | [Nanomedicine. Innovative applications in medicine] |